Company facts
- Headquarters
- Hampton, New Jersey
- Most recent report
- 8-K, filed Sep 22, 2026
- Incorporated
- Delaware
- Filings on record
- 1,000+ filings
- On EDGAR
- CIK 744218
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 80
News 8 of 186
Prospectuses and Registrations 8 of 72
- S-8 Registration statement for an employee plan Jun 26, 2026
- 424B5 Prospectus supplement for an offering Apr 2, 2026
- 424B5 Prospectus supplement for an offering Apr 1, 2026
- S-8 Registration statement for an employee plan Jun 6, 2025
- S-8 Registration statement for an employee plan Jun 14, 2024
- 424B5 Prospectus supplement for an offering Mar 1, 2024
- 424B5 Prospectus supplement for an offering Feb 28, 2024
- 424B5 Prospectus supplement for an offering Feb 26, 2024
Proxies 8 of 23
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 21, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 25, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 26, 2022
- DEF 14A Proxy statement for a shareholder vote Apr 27, 2021
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2020
- DEFA14A Extra proxy material May 7, 2019
Ownership 8 of 577
- SCHEDULE 13G/A Large holder reported a passive stake, amended Oct 7, 2026
- SCHEDULE 13G/A Large holder reported a passive stake, amended Aug 14, 2026
- SCHEDULE 13G Large holder reported a passive stake Aug 14, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
- 4 Insider reported a trade Jun 29, 2026
Other 8 of 62
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 21, 2025
- ARS Annual report sent to shareholders Apr 25, 2024
- ARS Annual report sent to shareholders Apr 25, 2023
- S-3MEF Jun 15, 2020
- EFFECT Notice that a registration became effective Jun 12, 2020
- CORRESP Reply to SEC staff Jun 12, 2020
- UPLOAD Comment letter from SEC staff Dec 12, 2019
Everything here comes from Celldex Therapeutics, Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.